On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
A new Diabetes Care registry study shows that Charcot neuro-osteoarthropathy is far more than a local foot disorder. Following diagnosis, nearly nine in ten patients required emergency hospitalization, almost one-third underwent amputation, and only 44% were alive and amputation-free at five years.
In 1,052 patients with diabetic foot ulcers, ten inflammation- and nutrition-derived ratios from routine labs tracked with amputation — and a machine-learning model combining them reached an AUC of 0.894. A cheap blood draw may help forecast which limbs are at risk.
Now published in Surgery: one clinician used conversational AI to vibe-code three interactive data platforms (local, national, and global), translating 15 years of amputation evidence into public tools in under a week at essentially no cost.
A new 5,698-patient real-world cohort from Valladolid (Del Río-Solá et al., Adv Wound Care 2026) reports 61.8% five-year survival overall, falling to 32.1% after major amputation — and concludes the diabetic foot ulcer should be treated as a marker of advanced systemic disease, not an isolated wound. The newest entry in a fifteen-year line of evidence putting DFU mortality squarely in the cancer conversation.
A new single-center study from the Netherlands quantifies the devastating outcomes of the diabetic foot attack: only 48.5% wound closure, 46% major amputation by 12 months, 26% one-year mortality, and 12-month amputation-free survival of just 39.7%. Time is tissue.
We’ve known for a long time that a diabetic foot ulcer (DFU) isn’t just a wound on the bottom of a foot—it’s a massive red flare for a patient’s overall health. But a recent nationwide study in Diabetes Care just put some sobering, and ultimately hopeful, numbers behind that reality. The data from this massive... Continue Reading →
When we speak of limb salvage, it is easy to think only in terms of preventing amputation. But as new evidence makes clear, the story does not end at the ankle. It is not just about preserving the limb—it is about extending life and helping people stay active, engaged, and moving. In a recent study,... Continue Reading →
Screenshot Ashu Rastogi, MD, and his team at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, have delivered an essential message in the most comprehensive prospective study of its kind: arterial stiffness kills—even when the ABI looks normal. In a paper just published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews , Gupta A, Singh... Continue Reading →
A recent cohort study published in Diabetologia by Naomi Holman, Arthur C. Yelland, Bob Young, Jonathan Valabhji, William Jeffcoate, and Fran Game highlights the alarming short-term mortality rates in individuals presenting with new diabetes-related foot ulcers (DFUs). The study analyzed data from 71,000 people registered in the National Diabetes Foot Care Audit (NDFA) in England... Continue Reading →
Diabetic Foot Disease (DFD) is a significant complication of Type 2 Diabetes Mellitus (T2DM), often leading to severe outcomes, including increased mortality. A recent study published in Cardiovascular Diabetology provides crucial insights into the risks associated with DFD, emphasizing the need for early intervention and improved management strategies for individuals with T2DM. Study Overview The... Continue Reading →
